Rectal Cancer Disappears After Experimental Use of Immunotherapy
Posted:
12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us